125 related articles for article (PubMed ID: 20457798)
1. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls.
von Kaisenberg CS; Wilting J; Dörk T; Nicolaides KH; Meinhold-Heerlein I; Hillemanns P; Brand-Saberi B
Mol Hum Reprod; 2010 Oct; 16(10):778-89. PubMed ID: 20457798
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS; Nicolaides KH; Brand-Saberi B
Hum Reprod; 1999 Mar; 14(3):823-6. PubMed ID: 10221720
[TBL] [Abstract][Full Text] [Related]
3. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
[TBL] [Abstract][Full Text] [Related]
4. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
von Kaisenberg CS; Krenn V; Ludwig M; Nicolaides KH; Brand-Saberi B
Anat Embryol (Berl); 1998 Feb; 197(2):105-24. PubMed ID: 9497154
[TBL] [Abstract][Full Text] [Related]
5. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
6. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
Böhlandt S; von Kaisenberg CS; Wewetzer K; Christ B; Nicolaides KH; Brand-Saberi B
Hum Reprod; 2000 May; 15(5):1155-8. PubMed ID: 10783369
[TBL] [Abstract][Full Text] [Related]
8. Distended jugular lymphatic sacs in fetuses with increased nuchal translucency: correlation with first-trimester findings in aberrant karyotypes.
Eckmann-Scholz C; Salmassi A; Jonat W; Alkatout I
J Matern Fetal Neonatal Med; 2014 Feb; 27(3):257-60. PubMed ID: 23718767
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
[TBL] [Abstract][Full Text] [Related]
10. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
12. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.
Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473
[TBL] [Abstract][Full Text] [Related]
13. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic malformation in human fetuses. A study of fetuses with Turner's syndrome or status Bonnevie-Ullrich.
van der Putte SC
Virchows Arch A Pathol Anat Histol; 1977 Nov; 376(3):233-46. PubMed ID: 145719
[TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.
von Kaisenberg CS; Prols F; Nicolaides KH; Maass N; Meinhold-Heerlein I; Brand-Saberi B
Hum Reprod; 2003 Dec; 18(12):2544-61. PubMed ID: 14645170
[TBL] [Abstract][Full Text] [Related]
17. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]